Evidence map›Paper›PMID 41974718›Full record

ArticleNature communications2026

Room-temperature electrochemical hydroxyalkylation of pyridines.

Chengqian Zhang, Maorui Wang, Pierre H Dixneuf, Min Zhang

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chengqian ZhangKey Lab of Functional Molecular Engineering of Guangdong Province, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou, China.
Maorui WangKey Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, People's Republic of China. mrwang@gxnu.edu.cn.
Pierre H DixneufUniversity of Rennes, ISCR, UMR CNRS 6226, Rennes, France.
Min ZhangKey Lab of Functional Molecular Engineering of Guangdong Province, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou, China. minzhang@scut.edu.cn.ORCID http://orcid.org/0000-0002-7023-8781

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22471080Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) 2025A1515012079
6 · The paper itself

Abstract

Direct and selective functionalization of ubiquitous pyridine scaffold is of paramount importance across numerous fields, yet remains challenging due to the inherent inertness of pyridines and the presence of competing reactive sites. Here, using an undivided cell equipped with a zinc cathode, a graphite anode, and a TEMPO mediator, we report a room-temperature electrochemical strategy that enables the direct hydroxyalkylation of diverse pyridines with readily available carbonyl compounds. This method features a broad substrate scope, operational simplicity, metal-free conditions, and high step/atom economy. It overcomes the limitations of conventional approaches requiring pre-functionalized substrates or stoichiometric activators, establishing a practical platform for direct access to C4- or C2-hydroxyalkyl pyridines, depending on the substitution pattern of the pyridine substrates. Mechanistic studies reveal that acetic acid activates both reactants, and the products are formed via cross-coupling of cathodic reduction-induced pyridyl radicals and hydroxy α-radicals followed by protonation and anodic oxidative aromatization.

Identifiers

PMID41974718
PMCPMC13250091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.